AstraZeneca has completed an agreement to divest its commercial rights to Seroquel (quetiapine fumarate immediate release) and Seroquel XR (quetiapine fumarate extended release) in Europe and Russia to Cheplapharm Arzneimittel GmbH (Cheplapharm).
Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.
AstraZeneca has completed an agreement to divest its commercial rights to Seroquel (quetiapine fumarate immediate release) and Seroquel XR (quetiapine fumarate extended release) in Europe and Russia to Cheplapharm Arzneimittel GmbH (Cheplapharm).
Taking the fight against the dreaded Nipha disease to a new level, researchers at Pune-based Indian Institute of Science Education and Research (IISER) have developed drug targets for the virus that causes the disease, using the molecular modeling approach.
Nipah virus outbreaks have very high mortality rates. They are over 70 per cent in Southeast Asia. The virus spreads via bodily secretions of bats, pigs and infected individuals. It was first detected in human population in 1998 in Malaysia, It made its way into Indian subcontinent with outbreaks in Bangladesh and India a few years later.
(adsbygoogle = window.adsbygoogle || []).push({});
Department of Pharmaceuticals has approved four medical devices park across India and around Rs. 25 crores finacial assiatance to each, informed by Sh Ashwini Kumar Choubey, Minister of State (Health and Family Welfare).
Indoco Remedies announced that its sterile manufacturing facility (Plant II) at Verna, Goa, has received EU GMP certification from the UK Health Regulator.
This is an outcome from the last successful inspection conducted by UK MHRA from 16th to 20th September 2019.
Biocon Ltd an innovation-led global biopharmaceuticals company and Equillium Inc, a clinical-stage biotechnology company leveraging deep understanding of immunobiology to develop products to treat severe autoimmune and inflammatory disorders, announced that they have expanded their collaboration and license agreement for itolizumab to grant Equillium exclusive rights for developing and commercializing itolizumab in Australia and New Zealand.
Equillium had originally secured exclusive rights to develop and commercialize Biocon’s novel biologic, itolizumab, for the U.S. and Canada markets, in May 2017.
A treatment for neurological disorder, Huntington's disease, could be in the offing. A group of researchers from the Indian Institute of Technology-Indore have identified three chemical molecules that could potentiually be used to arrest its progression.
Under Ayushman Bharat, Government has done addition to the primary health team at the Sub Health Centres and Health & Wellness Centres (HWC), would be the Mid-level Health Provider (MLHP) who would be a Community Health Officer. And National Health Mission (NHM) confirmed that Pharmacists are not eligible for same.
A common concern with oral vitamin B12 therapy is absorption especially in people suffering from anemia and gastrointestinal diseases. Researchers at the Council of Scientific and Industrial Research-Central Institute of Medicinal and Aromatic Plants (CSIR-CIMAP) have identified a plant extract that has shown potential in enhancing absorption of vitamin B12 through in vitro and in vivo bioassays.
The IIHMR University, Jaipur, has been ranked first amongst the cleanest higher educational institutions in India in the non-residential universities category in the Swachh Campus Rankings 2019 of Higher Education Institutions organized by the Ministry of Human Resource Development (MHRD), Govt. of India.
Eminence Business Media supports and work every day for empowering women and to create a platform for working women to network and grow, they organized the 2 nd Edition of its non-profitable “Remarkable Women Camaraderie 2019” on 29th November, 2019 at The Park Hotel, New Delhi.